Company: MDCXW
Filing Date: 2025-09-15
Form Type: 424B3
Source: 0001062993-25-015617
Chunk: 3

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-15
Form: 424B3
Chunk 3
---
401(d) of Regulation S-K and the Company has not entered into any transactions with Ms. Bonner that are reportable pursuant to Item 404(a) of Regulation S-K. Except as described above, there are no arrangements or understandings between Ms. Bonner and any other persons pursuant to which he will be appointed as an executive officer of the Company.

<div align='center'>SIGNATURES</div>

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

| MEDICUS PHARMA LTD. |                                                |
| By:                 | /s/ Raza Bokhari                               |
| Name:               | Dr. Raza Bokhari                               |
| Title:              | Executive Chairman and Chief Executive Officer |

Dated: September 12, 2025